0001140361-17-032607.txt : 20170817
0001140361-17-032607.hdr.sgml : 20170817
20170817163257
ACCESSION NUMBER: 0001140361-17-032607
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170815
FILED AS OF DATE: 20170817
DATE AS OF CHANGE: 20170817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hauer Jerome M
CENTRAL INDEX KEY: 0001294935
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 171039006
MAIL ADDRESS:
STREET 1: 4435 EASTGATE MALL
STREET 2: SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
doc1.xml
FORM 4
X0306
4
2017-08-15
0
0001367644
Emergent BioSolutions Inc.
EBS
0001294935
Hauer Jerome M
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2017-08-15
4
A
0
5153
25.47
A
29421
D
Common Stock
2017-08-15
4
S
0
10776
35.8342
D
18645
D
Stock Option (Right to Buy)
25.47
2017-08-15
4
M
0
5153
0.00
D
2022-01-21
Common Stock
5153
5152
D
Consists of an option granted on January 22, 2015 under the company's stock incentive plan as amended and restated.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.70 to $36.05, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.
/s/ Eric Burt, Attorney-in-fact
2017-08-17